Company

Financial Tearsheet

Company Overview

Petros is a Men’s Health pharmaceutical company that aims to develop complementary therapeutics designed for a man’s journey, often, we believe, centered around the ones he loves and lives for. Petros aims to revolutionize the art and science behind the way men approach their health emphasizing the critical elements of medication adherence, tolerability, preservation of organic function and the restoration of vitality.

Each element approached within an integrated and interdependent perspective, targeting tangible enhancements to their health outcomes. Ultimately, Petros seeks to establish new foundations to Men’s Health that center around the whole of a man’s life and function.

Recent Financial News

IR Contacts

CoreIR

IR@PetrosPharma.com

Recent SEC Filings

Management Team

Fady Boctor, President, Chief Commercial Officer

Mitch Arnold, VP of Finance, Chief Accounting Officer

Robert Weinstein, Interim Chief Financial Officer

Andy Gesek, President of Timm Medical Technologies (subsidiary of Petros Pharmaceuticals)

Board of Directors

John Shulman, Executive Chairman of the Board

Josh Silverman, Vice-Chairman of the Board

Greg Bradley, Board of Directors

Wayne Walker, Board of Directors

Bruce Bernstein, Board of Directors